The U.S. Food and Drug Administration today announced that it has awarded 21 new clinical trial research grants totaling more than $23 million over the next four years to boost the development of products for patients with rare diseases. These new grants were awarded to principal investigators from academia and industry with research spanning domestic and international clinical sites.
from Food and Drug Administration--Press Releases http://ift.tt/2diyaP8
via IFTTT
No comments:
Post a Comment